Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?

The Lancet

Volumn 344, Issue 8922, 1994, Pages 620-621

  Colombel, Jean Frédéric ^a,b,c,d,e   Brabant, Gilles ^a,b,c,d,e   Gubler, Marie Claire ^a,b,c,d,e   Locquet, André ^a,b,c,d,e   Comes, Marie Christine ^a,b,c,d,e   Dehennault, Maud ^a,b,c,d,e   Delcroix, Michel ^a,b,c,d,e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier Saint Philibert GHICL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Service de Pédiatrie Hôpital St Antoine ^*  (Belgium)

^e Service d'Hépato Gastroentérologie Hôpital St Philibert ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; CASE REPORT; CROHN DISEASE; FEMALE; HUMAN; KIDNEY FAILURE; LETTER; MALE; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL;

EID: 0028074860     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)92009-5     Document Type: Letter

References (5)

1. Oral 5-aminosahcylic acid for inflammatory bowel disease in pregnancy: safety and clinical course
2. Renal dysgenesis in a monozygotic twin: association with an utero exposure to indomethacin
3. Fetal indomethacin syndrome
4. Disposition of 5-aminosalicylic acid and N-acetyl-5-ammosalicylic acid in fetal and maternal body fluids during treatment with different 5-aminosalicylic acid preparations